The United States is home to around 70 million baby boomers, and many of them are now older than 65. As people age, health problems related to the heart and blood vessels become more common.
To prevent strokes, heart attacks, and blood clots, many older adults are prescribed blood-thinning medications such as warfarin. These medicines can be life-saving, but they also raise concerns, especially when older people fall and hit their heads.
Falls are the leading cause of injury and injury-related death among older adults. In 2021 alone, falls caused about 38,000 deaths and led to nearly 3 million emergency department visits in the United States.
Beyond the human cost, the financial burden is enormous. Non-fatal falls among older adults cost the health care system around 80 billion dollars in 2020, a sharp increase compared to just a few years earlier.
One of the biggest worries when an older person falls is bleeding in the brain. This risk becomes even more concerning when the person is taking a blood thinner. Warfarin works by slowing the blood’s ability to clot, which helps prevent dangerous clots but also makes bleeding harder to stop.
Because of this, many doctors believe that people taking warfarin, especially those with very high blood-thinning levels, face a much higher risk of brain bleeding after a head injury.
Doctors measure the strength of warfarin using a blood test called the International Normalized Ratio, or INR. If the INR is too low, the medicine may not protect against clots. If it is too high, the risk of bleeding is thought to rise sharply.
Current emergency care guidelines often call for extra monitoring, repeat brain scans, and longer hospital stays for people on warfarin who suffer head injuries, especially if their INR is high.
However, researchers at Florida Atlantic University’s Charles E. Schmidt College of Medicine wanted to test whether this fear is truly supported by evidence. They noticed that many earlier studies linking high INR levels to brain bleeding were small or limited in scope.
To address this gap, they conducted a large study focusing on adults aged 65 and older who came to the emergency department after a fall-related head injury.
The study took place over one year at two major trauma centers in South Florida. Researchers examined the records of 2,686 patients who were treated after a fall. Some of these patients were taking warfarin before their injury, while others were not taking any blood-thinning medication.
The team carefully reviewed medical histories, physical exams, blood test results, and brain scans. They also followed up for two weeks after the injury to check for delayed brain bleeding.
The results, published in the American Journal of Emergency Medicine, were surprising. Overall, about 11 percent of all patients experienced bleeding in the brain after their head injury.
Among patients who were not taking blood thinners, about 6 percent had brain bleeding. Among those taking warfarin, the rate was about 7 percent. This difference was small and not considered statistically significant.
Even more unexpected was how INR levels related to bleeding risk. Patients with INR levels above 3.0 did not have higher rates of brain bleeding than those with lower levels.
In fact, no brain bleeding occurred in patients with extremely high INR levels above 5.0. The highest risk was seen in patients whose INR levels were below the recommended range. Nearly 20 percent of these patients developed brain bleeding.
These findings challenge the long-held belief that higher warfarin levels automatically mean greater danger after head trauma.
According to Dr. Richard Shih, the senior author of the study, the data suggest that poorly controlled or insufficient blood thinning may be more dangerous than higher-than-normal levels. This points to the importance of proper warfarin management rather than avoiding or aggressively reversing it after every fall.
The study also examined the severity of brain bleeding, length of hospital stays, and survival rates. The researchers did not find worse outcomes in patients with higher INR levels. This raises important questions about whether current emergency care practices may lead to unnecessary tests, hospital admissions, and health care costs without improving patient safety.
From a broader perspective, these findings are especially important as the older population continues to grow, particularly in places like South Florida. Emergency departments are under increasing pressure, and smarter, evidence-based decisions can help protect patients while using resources more wisely.
In reviewing and analyzing this study, the main takeaway is that fear of high INR levels may be overstated when it comes to fall-related head injuries in older adults. The results suggest that stable and well-managed blood-thinning therapy may not increase brain bleeding risk as much as once thought.
Instead, poorly controlled anticoagulation appears to pose a greater danger. While more research is needed to confirm these findings in other settings, this study offers strong evidence that emergency care guidelines may need to be updated.
By focusing on balanced anticoagulation management rather than automatic escalation of care, doctors may be able to improve outcomes, reduce unnecessary interventions, and provide safer, more patient-centered care for older adults.
If you care about stroke, please read studies about how to eat to prevent stroke, and diets high in flavonoids could help reduce stroke risk.
For more health information, please see recent studies about how Mediterranean diet could protect your brain health, and wild blueberries can benefit your heart and brain.
The study is published in The American Journal of Emergency Medicine.
Copyright © 2025 Knowridge Science Report. All rights reserved.
